CA2625222A1 - Antibody polypeptide library screening and selected antibody polypeptides - Google Patents

Info

Publication number

CA2625222A1

CA2625222A1 CA002625222A CA2625222A CA2625222A1 CA 2625222 A1 CA2625222 A1 CA 2625222A1 CA 002625222 A CA002625222 A CA 002625222A CA 2625222 A CA2625222 A CA 2625222A CA 2625222 A1 CA2625222 A1 CA 2625222A1

Authority

CA

Canada

Prior art keywords

antibody

variable domain

chain variable

light chain

heavy chain

Prior art date

2005-10-11

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 364
• 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 352
• 229920001184 polypeptide Polymers 0.000 title claims abstract description 349
• 238000012216 screening Methods 0.000 title abstract description 12
• 238000000034 method Methods 0.000 claims abstract description 294
• 239000003446 ligand Substances 0.000 claims description 477
• 241000282414 Homo sapiens Species 0.000 claims description 210
• 108091007433 antigens Proteins 0.000 claims description 165
• 102000036639 antigens Human genes 0.000 claims description 165
• 239000000427 antigen Substances 0.000 claims description 164
• 230000027455 binding Effects 0.000 claims description 152
• 108090000623 proteins and genes Proteins 0.000 claims description 150
• 210000003719 b-lymphocyte Anatomy 0.000 claims description 133
• 102000004169 proteins and genes Human genes 0.000 claims description 84
• 239000012634 fragment Substances 0.000 claims description 67
• 210000004602 germ cell Anatomy 0.000 claims description 61
• 108091008874 T cell receptors Proteins 0.000 claims description 52
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 52
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 49
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 49
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 41
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 41
• 239000004471 Glycine Substances 0.000 claims description 35
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 32
• 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 32
• 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 claims description 32
• 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims description 31
• 201000010099 disease Diseases 0.000 claims description 28
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 28
• 102000005962 receptors Human genes 0.000 claims description 25
• 108020003175 receptors Proteins 0.000 claims description 25
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 24
• 108010026228 mRNA guanylyltransferase Proteins 0.000 claims description 23
• 241001515965 unidentified phage Species 0.000 claims description 21
• -1 IgE Proteins 0.000 claims description 20
• 102000004190 Enzymes Human genes 0.000 claims description 19
• 108090000790 Enzymes Proteins 0.000 claims description 19
• 241001529936 Murinae Species 0.000 claims description 19
• 101710120037 Toxin CcdB Proteins 0.000 claims description 19
• 210000005105 peripheral blood lymphocyte Anatomy 0.000 claims description 17
• 238000002560 therapeutic procedure Methods 0.000 claims description 17
• 241001465754 Metazoa Species 0.000 claims description 16
• 230000035772 mutation Effects 0.000 claims description 16
• 229960001134 von willebrand factor Drugs 0.000 claims description 16
• 238000002823 phage display Methods 0.000 claims description 14
• 239000012636 effector Substances 0.000 claims description 13
• 108010074328 Interferon-gamma Proteins 0.000 claims description 12
• 108010071390 Serum Albumin Proteins 0.000 claims description 12
• 102000007562 Serum Albumin Human genes 0.000 claims description 12
• 210000004698 lymphocyte Anatomy 0.000 claims description 12
• 230000002265 prevention Effects 0.000 claims description 12
• 101100112922 Candida albicans CDR3 gene Proteins 0.000 claims description 11
• 239000003814 drug Substances 0.000 claims description 11
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims description 11
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims description 11
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims description 11
• 241000894007 species Species 0.000 claims description 10
• 231100000765 toxin Toxicity 0.000 claims description 10
• 239000003053 toxin Substances 0.000 claims description 10
• 108700012359 toxins Proteins 0.000 claims description 10
• 108010047303 von Willebrand Factor Proteins 0.000 claims description 10
• 101710132601 Capsid protein Proteins 0.000 claims description 9
• 101710094648 Coat protein Proteins 0.000 claims description 9
• 102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims description 9
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical group C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 9
• 101710125418 Major capsid protein Proteins 0.000 claims description 9
• 101710141454 Nucleoprotein Proteins 0.000 claims description 9
• 101710083689 Probable capsid protein Proteins 0.000 claims description 9
• 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims description 9
• 239000004475 Arginine Chemical group 0.000 claims description 8
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Chemical group OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 8
• 102000008070 Interferon-gamma Human genes 0.000 claims description 7
• 229960003130 interferon gamma Drugs 0.000 claims description 7
• 102000009027 Albumins Human genes 0.000 claims description 6
• 108010088751 Albumins Proteins 0.000 claims description 6
• 102000013455 Amyloid beta-Peptides Human genes 0.000 claims description 6
• 108010090849 Amyloid beta-Peptides Proteins 0.000 claims description 6
• 101800001718 Amyloid-beta protein Proteins 0.000 claims description 6
• 101000600756 Homo sapiens 3-phosphoinositide-dependent protein kinase 1 Proteins 0.000 claims description 5
• 101001117146 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Proteins 0.000 claims description 5
• 102100024148 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Human genes 0.000 claims description 5
• RTQWWZBSTRGEAV-PKHIMPSTSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound CNC(=O)NC1=CC=C(C[C@@H](CN(CC(C)N(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 RTQWWZBSTRGEAV-PKHIMPSTSA-N 0.000 claims description 4
• 229960003297 gemtuzumab ozogamicin Drugs 0.000 claims description 4
• 229940022353 herceptin Drugs 0.000 claims description 4
• 229960001001 ibritumomab tiuxetan Drugs 0.000 claims description 4
• 229960005267 tositumomab Drugs 0.000 claims description 4
• 102100027998 Macrophage metalloelastase Human genes 0.000 claims description 3
• 229940120638 avastin Drugs 0.000 claims description 3
• 229940048921 humira Drugs 0.000 claims description 3
• 229940116176 remicade Drugs 0.000 claims description 3
• 229940107685 reopro Drugs 0.000 claims description 3
• 229940115586 simulect Drugs 0.000 claims description 3
• 229940036185 synagis Drugs 0.000 claims description 3
• 229940099073 xolair Drugs 0.000 claims description 3
• 102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 claims description 2
• 108010001831 LDL receptors Proteins 0.000 claims description 2
• 230000009824 affinity maturation Effects 0.000 claims description 2
• 108010068617 neonatal Fc receptor Proteins 0.000 claims description 2
• 101000577881 Homo sapiens Macrophage metalloelastase Proteins 0.000 claims 2
• 229940112129 campath Drugs 0.000 claims 2
• 229940082789 erbitux Drugs 0.000 claims 2
• 102000000853 LDL receptors Human genes 0.000 claims 1
• 108010003723 Single-Domain Antibodies Proteins 0.000 claims 1
• 238000011161 development Methods 0.000 abstract description 10
• 230000018109 developmental process Effects 0.000 abstract description 10
• 229940027941 immunoglobulin g Drugs 0.000 description 87
• 235000018102 proteins Nutrition 0.000 description 82
• 210000004027 cell Anatomy 0.000 description 78
• 230000014509 gene expression Effects 0.000 description 77
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 70
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 70
• 125000003275 alpha amino acid group Chemical group 0.000 description 43
• 235000001014 amino acid Nutrition 0.000 description 43
• 102000004388 Interleukin-4 Human genes 0.000 description 40
• 229940024606 amino acid Drugs 0.000 description 40
• 150000001413 amino acids Chemical class 0.000 description 40
• 108090000978 Interleukin-4 Proteins 0.000 description 39
• 239000013598 vector Substances 0.000 description 37
• 102000013691 Interleukin-17 Human genes 0.000 description 35
• 108050003558 Interleukin-17 Proteins 0.000 description 35
• 102000000588 Interleukin-2 Human genes 0.000 description 32
• 108010002350 Interleukin-2 Proteins 0.000 description 32
• 239000013615 primer Substances 0.000 description 32
• 150000007523 nucleic acids Chemical class 0.000 description 31
• 108060003951 Immunoglobulin Proteins 0.000 description 29
• 102000000743 Interleukin-5 Human genes 0.000 description 29
• 102000018358 immunoglobulin Human genes 0.000 description 29
• 102000000589 Interleukin-1 Human genes 0.000 description 28
• 108010002352 Interleukin-1 Proteins 0.000 description 28
• 102100033400 4F2 cell-surface antigen heavy chain Human genes 0.000 description 27
• 102000004127 Cytokines Human genes 0.000 description 27
• 108090000695 Cytokines Proteins 0.000 description 27
• 101000800023 Homo sapiens 4F2 cell-surface antigen heavy chain Proteins 0.000 description 27
• 108010002616 Interleukin-5 Proteins 0.000 description 26
• 108020004705 Codon Proteins 0.000 description 25
• 102000013462 Interleukin-12 Human genes 0.000 description 25
• 108010065805 Interleukin-12 Proteins 0.000 description 25
• 239000000203 mixture Substances 0.000 description 25
• 102000039446 nucleic acids Human genes 0.000 description 25
• 108020004707 nucleic acids Proteins 0.000 description 25
• 229960002449 glycine Drugs 0.000 description 23
• 208000006673 asthma Diseases 0.000 description 21
• 230000000392 somatic effect Effects 0.000 description 21
• 102000003816 Interleukin-13 Human genes 0.000 description 20
• 108090000176 Interleukin-13 Proteins 0.000 description 20
• 108090000171 Interleukin-18 Proteins 0.000 description 20
• 102000003810 Interleukin-18 Human genes 0.000 description 20
• 102000004889 Interleukin-6 Human genes 0.000 description 20
• 108090001005 Interleukin-6 Proteins 0.000 description 20
• 239000000047 product Substances 0.000 description 20
• 230000000694 effects Effects 0.000 description 19
• 238000003752 polymerase chain reaction Methods 0.000 description 19
• 239000013604 expression vector Substances 0.000 description 18
• 230000006870 function Effects 0.000 description 18
• 238000004519 manufacturing process Methods 0.000 description 18
• 239000002773 nucleotide Substances 0.000 description 18
• 102000000646 Interleukin-3 Human genes 0.000 description 17
• 108010002386 Interleukin-3 Proteins 0.000 description 17
• 229940088598 enzyme Drugs 0.000 description 17
• 229940076264 interleukin-3 Drugs 0.000 description 17
• 210000002966 serum Anatomy 0.000 description 17
• 108020004414 DNA Proteins 0.000 description 16
• 238000002965 ELISA Methods 0.000 description 16
• 102000004890 Interleukin-8 Human genes 0.000 description 16
• 108090001007 Interleukin-8 Proteins 0.000 description 16
• 210000004369 blood Anatomy 0.000 description 16
• 239000008280 blood Substances 0.000 description 16
• 229940096397 interleukin-8 Drugs 0.000 description 16
• XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 16
• 125000003729 nucleotide group Chemical group 0.000 description 16
• 102000049772 Interleukin-16 Human genes 0.000 description 15
• 101800003050 Interleukin-16 Proteins 0.000 description 15
• 238000001727 in vivo Methods 0.000 description 15
• 231100000617 superantigen Toxicity 0.000 description 15
• 229960000814 tetanus toxoid Drugs 0.000 description 15
• 241000699670 Mus sp. Species 0.000 description 14
• 238000013459 approach Methods 0.000 description 14
• 238000000338 in vitro Methods 0.000 description 14
• 102000003812 Interleukin-15 Human genes 0.000 description 13
• 108090000172 Interleukin-15 Proteins 0.000 description 13
• 238000009396 hybridization Methods 0.000 description 13
• 230000001225 therapeutic effect Effects 0.000 description 13
• 102000014914 Carrier Proteins Human genes 0.000 description 12
• 102000003815 Interleukin-11 Human genes 0.000 description 12
• 108090000177 Interleukin-11 Proteins 0.000 description 12
• 241000124008 Mammalia Species 0.000 description 12
• 101150117115 V gene Proteins 0.000 description 12
• 238000010276 construction Methods 0.000 description 12
• 229910052751 metal Inorganic materials 0.000 description 12
• 239000002184 metal Substances 0.000 description 12
• 235000002198 Annona diversifolia Nutrition 0.000 description 11
• 241000588724 Escherichia coli Species 0.000 description 11
• 206010020751 Hypersensitivity Diseases 0.000 description 11
• 206010061218 Inflammation Diseases 0.000 description 11
• 102000003814 Interleukin-10 Human genes 0.000 description 11
• 108090000174 Interleukin-10 Proteins 0.000 description 11
• 102000000585 Interleukin-9 Human genes 0.000 description 11
• 108010002335 Interleukin-9 Proteins 0.000 description 11
• 102000015696 Interleukins Human genes 0.000 description 11
• 108010063738 Interleukins Proteins 0.000 description 11
• 230000004913 activation Effects 0.000 description 11
• 208000026935 allergic disease Diseases 0.000 description 11
• 239000000872 buffer Substances 0.000 description 11
• 238000010367 cloning Methods 0.000 description 11
• 230000000295 complement effect Effects 0.000 description 11
• 230000004054 inflammatory process Effects 0.000 description 11
• 229940076144 interleukin-10 Drugs 0.000 description 11
• 206010039073 rheumatoid arthritis Diseases 0.000 description 11
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 10
• 241000282832 Camelidae Species 0.000 description 10
• 241000282836 Camelus dromedarius Species 0.000 description 10
• 102000000704 Interleukin-7 Human genes 0.000 description 10
• 108010002586 Interleukin-7 Proteins 0.000 description 10
• 241000699666 Mus <mouse, genus> Species 0.000 description 10
• 108091034117 Oligonucleotide Proteins 0.000 description 10
• 230000009285 allergic inflammation Effects 0.000 description 10
• 230000007815 allergy Effects 0.000 description 10
• 238000004458 analytical method Methods 0.000 description 10
• 206010003246 arthritis Diseases 0.000 description 10
• 238000003556 assay Methods 0.000 description 10
• 230000015572 biosynthetic process Effects 0.000 description 10
• 150000001455 metallic ions Chemical class 0.000 description 10
• 238000003786 synthesis reaction Methods 0.000 description 10
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 9
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 9
• 241000282842 Lama glama Species 0.000 description 9
• 101000686985 Mouse mammary tumor virus (strain C3H) Protein PR73 Proteins 0.000 description 9
• 210000000628 antibody-producing cell Anatomy 0.000 description 9
• 108091008324 binding proteins Proteins 0.000 description 9
• 230000002068 genetic effect Effects 0.000 description 9
• 210000000822 natural killer cell Anatomy 0.000 description 9
• 230000035755 proliferation Effects 0.000 description 9
• 230000000069 prophylactic effect Effects 0.000 description 9
• 230000010076 replication Effects 0.000 description 9
• 230000004044 response Effects 0.000 description 9
• 230000002195 synergetic effect Effects 0.000 description 9
• 210000000987 immune system Anatomy 0.000 description 8
• 238000002703 mutagenesis Methods 0.000 description 8
• 231100000350 mutagenesis Toxicity 0.000 description 8
• 239000011347 resin Substances 0.000 description 8
• 229920005989 resin Polymers 0.000 description 8
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 8
• 208000011231 Crohn disease Diseases 0.000 description 7
• 108010038484 Interleukin-5 Receptors Proteins 0.000 description 7
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 7
• 208000037883 airway inflammation Diseases 0.000 description 7
• 238000000137 annealing Methods 0.000 description 7
• 230000001580 bacterial effect Effects 0.000 description 7
• 238000001514 detection method Methods 0.000 description 7
• 230000004069 differentiation Effects 0.000 description 7
• 230000002163 immunogen Effects 0.000 description 7
• 230000006698 induction Effects 0.000 description 7
• 239000000126 substance Substances 0.000 description 7
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
• 108091026890 Coding region Proteins 0.000 description 6
• 102000008186 Collagen Human genes 0.000 description 6
• 108010035532 Collagen Proteins 0.000 description 6
• HNDVDQJCIGZPNO-UHFFFAOYSA-N Histidine Chemical compound OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 6
• 101001128431 Homo sapiens Myeloid-derived growth factor Proteins 0.000 description 6
• 102100036680 Interleukin-25 Human genes 0.000 description 6
• 108010038452 Interleukin-3 Receptors Proteins 0.000 description 6
• 206010028980 Neoplasm Diseases 0.000 description 6
• 108091028043 Nucleic acid sequence Proteins 0.000 description 6
• 230000006044 T cell activation Effects 0.000 description 6
• 108010009583 Transforming Growth Factors Proteins 0.000 description 6
• 102000009618 Transforming Growth Factors Human genes 0.000 description 6
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 6
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
• 230000003321 amplification Effects 0.000 description 6
• 208000010668 atopic eczema Diseases 0.000 description 6
• 239000012148 binding buffer Substances 0.000 description 6
• 229920001436 collagen Polymers 0.000 description 6
• 210000002889 endothelial cell Anatomy 0.000 description 6
• 238000005516 engineering process Methods 0.000 description 6
• 230000004927 fusion Effects 0.000 description 6
• 239000003102 growth factor Substances 0.000 description 6
• 210000003630 histaminocyte Anatomy 0.000 description 6
• 230000001900 immune effect Effects 0.000 description 6
• 230000005764 inhibitory process Effects 0.000 description 6
• 230000001404 mediated effect Effects 0.000 description 6
• 238000003199 nucleic acid amplification method Methods 0.000 description 6
• 239000013612 plasmid Substances 0.000 description 6
• 150000003839 salts Chemical class 0.000 description 6
• NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 5
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 5
• 241000894006 Bacteria Species 0.000 description 5
• 102100021935 C-C motif chemokine 26 Human genes 0.000 description 5
• 101100180402 Caenorhabditis elegans jun-1 gene Proteins 0.000 description 5
• 101710139422 Eotaxin Proteins 0.000 description 5
• 102100023688 Eotaxin Human genes 0.000 description 5
• 108010049003 Fibrinogen Proteins 0.000 description 5
• 102000008946 Fibrinogen Human genes 0.000 description 5
• 241000282412 Homo Species 0.000 description 5
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 5
• 102100037850 Interferon gamma Human genes 0.000 description 5
• 102000013566 Plasminogen Human genes 0.000 description 5
• 108010051456 Plasminogen Proteins 0.000 description 5
• 241000219061 Rheum Species 0.000 description 5
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
• 102000009270 Tumour necrosis factor alpha Human genes 0.000 description 5
• 108050000101 Tumour necrosis factor alpha Proteins 0.000 description 5
• 241000700605 Viruses Species 0.000 description 5
• 230000001154 acute effect Effects 0.000 description 5
• 239000011324 bead Substances 0.000 description 5
• 230000008901 benefit Effects 0.000 description 5
• 238000009826 distribution Methods 0.000 description 5
• 230000009977 dual effect Effects 0.000 description 5
• 210000003979 eosinophil Anatomy 0.000 description 5
• 229940012952 fibrinogen Drugs 0.000 description 5
• 230000037433 frameshift Effects 0.000 description 5
• 230000012010 growth Effects 0.000 description 5
• 239000001963 growth medium Substances 0.000 description 5
• 108010021083 hen egg lysozyme Proteins 0.000 description 5
• 210000004408 hybridoma Anatomy 0.000 description 5
• NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 5
• 229940072221 immunoglobulins Drugs 0.000 description 5
• 230000001965 increasing effect Effects 0.000 description 5
• 229940117681 interleukin-12 Drugs 0.000 description 5
• 210000003127 knee Anatomy 0.000 description 5
• 210000004072 lung Anatomy 0.000 description 5
• 210000001616 monocyte Anatomy 0.000 description 5
• 210000000440 neutrophil Anatomy 0.000 description 5
• 230000008569 process Effects 0.000 description 5
• 230000009467 reduction Effects 0.000 description 5
• 238000003757 reverse transcription PCR Methods 0.000 description 5
• 230000028327 secretion Effects 0.000 description 5
• 238000010187 selection method Methods 0.000 description 5
• 239000007787 solid Substances 0.000 description 5
• 239000000758 substrate Substances 0.000 description 5
• 239000006228 supernatant Substances 0.000 description 5
• 238000011282 treatment Methods 0.000 description 5
• 229920000936 Agarose Polymers 0.000 description 4
• 230000003844 B-cell-activation Effects 0.000 description 4
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 4
• 206010009944 Colon cancer Diseases 0.000 description 4
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
• 102000006354 HLA-DR Antigens Human genes 0.000 description 4
• 108010058597 HLA-DR Antigens Proteins 0.000 description 4
• 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 4
• 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 description 4
• 101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 description 4
• 101000617725 Homo sapiens Pregnancy-specific beta-1-glycoprotein 2 Proteins 0.000 description 4
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 4
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 4
• 102000013264 Interleukin-23 Human genes 0.000 description 4
• 108010065637 Interleukin-23 Proteins 0.000 description 4
• 102000010786 Interleukin-5 Receptors Human genes 0.000 description 4
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
• MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 4
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
• 108700012920 TNF Proteins 0.000 description 4
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
• 230000033228 biological regulation Effects 0.000 description 4
• 210000000988 bone and bone Anatomy 0.000 description 4
• 201000011510 cancer Diseases 0.000 description 4
• 210000000845 cartilage Anatomy 0.000 description 4
• 230000001413 cellular effect Effects 0.000 description 4
• 239000003795 chemical substances by application Substances 0.000 description 4
• 238000004587 chromatography analysis Methods 0.000 description 4
• 230000001684 chronic effect Effects 0.000 description 4
• 239000003636 conditioned culture medium Substances 0.000 description 4
• 230000001419 dependent effect Effects 0.000 description 4
• 239000000539 dimer Substances 0.000 description 4
• 229940079593 drug Drugs 0.000 description 4
• 230000002255 enzymatic effect Effects 0.000 description 4
• 230000036541 health Effects 0.000 description 4
• 230000028993 immune response Effects 0.000 description 4
• 230000005847 immunogenicity Effects 0.000 description 4
• 238000001114 immunoprecipitation Methods 0.000 description 4
• 230000001939 inductive effect Effects 0.000 description 4
• 238000002347 injection Methods 0.000 description 4
• 239000007924 injection Substances 0.000 description 4
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
• 230000003993 interaction Effects 0.000 description 4
• 108010074108 interleukin-21 Proteins 0.000 description 4
• 229940028885 interleukin-4 Drugs 0.000 description 4
• 229940118526 interleukin-9 Drugs 0.000 description 4
• 230000035800 maturation Effects 0.000 description 4
• 230000006798 recombination Effects 0.000 description 4
• 238000005215 recombination Methods 0.000 description 4
• 238000012552 review Methods 0.000 description 4
• 238000012163 sequencing technique Methods 0.000 description 4
• 239000000243 solution Substances 0.000 description 4
• 230000009870 specific binding Effects 0.000 description 4
• 238000006467 substitution reaction Methods 0.000 description 4
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 4
• 238000012360 testing method Methods 0.000 description 4
• 238000001262 western blot Methods 0.000 description 4
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
• 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 3
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 3
• 108010081589 Becaplermin Proteins 0.000 description 3
• 102000004506 Blood Proteins Human genes 0.000 description 3
• 108010017384 Blood Proteins Proteins 0.000 description 3
• 102100023698 C-C motif chemokine 17 Human genes 0.000 description 3
• 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 description 3
• 201000009030 Carcinoma Diseases 0.000 description 3
• 108010078791 Carrier Proteins Proteins 0.000 description 3
• 102000000844 Cell Surface Receptors Human genes 0.000 description 3
• 108010001857 Cell Surface Receptors Proteins 0.000 description 3
• 108010078239 Chemokine CX3CL1 Proteins 0.000 description 3
• 239000003155 DNA primer Substances 0.000 description 3
• 206010012434 Dermatitis allergic Diseases 0.000 description 3
• 241000701959 Escherichia virus Lambda Species 0.000 description 3
• 108090001047 Fibroblast growth factor 10 Proteins 0.000 description 3
• 102100037362 Fibronectin Human genes 0.000 description 3
• 108010067306 Fibronectins Proteins 0.000 description 3
• 102000013818 Fractalkine Human genes 0.000 description 3
• 102000016355 Granulocyte-Macrophage Colony-Stimulating Factor Receptors Human genes 0.000 description 3
• 108010092372 Granulocyte-Macrophage Colony-Stimulating Factor Receptors Proteins 0.000 description 3
• 102000013271 Hemopexin Human genes 0.000 description 3
• 108010026027 Hemopexin Proteins 0.000 description 3
• 101000978362 Homo sapiens C-C motif chemokine 17 Proteins 0.000 description 3
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 3
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 3
• 102000039989 IL-17 family Human genes 0.000 description 3
• 108091069193 IL-17 family Proteins 0.000 description 3
• 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 3
• 102100036678 Interleukin-27 subunit alpha Human genes 0.000 description 3
• 102000010790 Interleukin-3 Receptors Human genes 0.000 description 3
• 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 3
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
• 102000004083 Lymphotoxin-alpha Human genes 0.000 description 3
• 108090000542 Lymphotoxin-alpha Proteins 0.000 description 3
• 206010035226 Plasma cell myeloma Diseases 0.000 description 3
• 201000004681 Psoriasis Diseases 0.000 description 3
• 108010025832 RANK Ligand Proteins 0.000 description 3
• 241000700159 Rattus Species 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 108700028909 Serum Amyloid A Proteins 0.000 description 3
• 102000054727 Serum Amyloid A Human genes 0.000 description 3
• 230000006052 T cell proliferation Effects 0.000 description 3
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
• 239000004473 Threonine Substances 0.000 description 3
• 108010033576 Transferrin Receptors Proteins 0.000 description 3
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 3
• 102100024568 Tumor necrosis factor ligand superfamily member 11 Human genes 0.000 description 3
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 3
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 3
• 102100039037 Vascular endothelial growth factor A Human genes 0.000 description 3
• 201000000028 adult respiratory distress syndrome Diseases 0.000 description 3
• 238000001042 affinity chromatography Methods 0.000 description 3
• 229960003767 alanine Drugs 0.000 description 3
• 235000004279 alanine Nutrition 0.000 description 3
• 230000000172 allergic effect Effects 0.000 description 3
• 230000006907 apoptotic process Effects 0.000 description 3
• 229960001230 asparagine Drugs 0.000 description 3
• 235000009582 asparagine Nutrition 0.000 description 3
• 229940009098 aspartate Drugs 0.000 description 3
• 201000008937 atopic dermatitis Diseases 0.000 description 3
• 210000004899 c-terminal region Anatomy 0.000 description 3
• 244000309466 calf Species 0.000 description 3
• 230000020411 cell activation Effects 0.000 description 3
• 239000013599 cloning vector Substances 0.000 description 3
• 238000007796 conventional method Methods 0.000 description 3
• 229960002433 cysteine Drugs 0.000 description 3
• 235000018417 cysteine Nutrition 0.000 description 3
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
• 102000003675 cytokine receptors Human genes 0.000 description 3
• 108010057085 cytokine receptors Proteins 0.000 description 3
• 238000012217 deletion Methods 0.000 description 3
• 230000037430 deletion Effects 0.000 description 3
• 239000008121 dextrose Substances 0.000 description 3
• 239000012149 elution buffer Substances 0.000 description 3
• 239000002158 endotoxin Substances 0.000 description 3
• 210000002950 fibroblast Anatomy 0.000 description 3
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
• 238000004108 freeze drying Methods 0.000 description 3
• 108020001507 fusion proteins Proteins 0.000 description 3
• 102000037865 fusion proteins Human genes 0.000 description 3
• 239000000499 gel Substances 0.000 description 3
• 230000003394 haemopoietic effect Effects 0.000 description 3
• 229940099472 immunoglobulin a Drugs 0.000 description 3
• 230000008595 infiltration Effects 0.000 description 3
• 238000001764 infiltration Methods 0.000 description 3
• 239000003112 inhibitor Substances 0.000 description 3
• 102000014909 interleukin-1 receptor activity proteins Human genes 0.000 description 3
• 108040006732 interleukin-1 receptor activity proteins Proteins 0.000 description 3
• 230000017306 interleukin-6 production Effects 0.000 description 3
• 108040006858 interleukin-6 receptor activity proteins Proteins 0.000 description 3
• 238000002372 labelling Methods 0.000 description 3
• 229920006008 lipopolysaccharide Polymers 0.000 description 3
• 239000003550 marker Substances 0.000 description 3
• 210000003622 mature neutrocyte Anatomy 0.000 description 3
• 239000002609 medium Substances 0.000 description 3
• 108020004999 messenger RNA Proteins 0.000 description 3
• 206010028417 myasthenia gravis Diseases 0.000 description 3
• 210000002997 osteoclast Anatomy 0.000 description 3
• 230000007170 pathology Effects 0.000 description 3
• 230000037452 priming Effects 0.000 description 3
• 230000000770 proinflammatory effect Effects 0.000 description 3
• 230000002685 pulmonary effect Effects 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 238000003127 radioimmunoassay Methods 0.000 description 3
• 230000001105 regulatory effect Effects 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 230000004043 responsiveness Effects 0.000 description 3
• 102000029752 retinol binding Human genes 0.000 description 3
• 108091000053 retinol binding Proteins 0.000 description 3
• 239000000523 sample Substances 0.000 description 3
• 210000003491 skin Anatomy 0.000 description 3
• 206010040882 skin lesion Diseases 0.000 description 3
• 231100000444 skin lesion Toxicity 0.000 description 3
• 239000011780 sodium chloride Substances 0.000 description 3
• 238000010561 standard procedure Methods 0.000 description 3
• 230000000638 stimulation Effects 0.000 description 3
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 3
• 229960002898 threonine Drugs 0.000 description 3
• 210000001519 tissue Anatomy 0.000 description 3
• 239000002753 trypsin inhibitor Substances 0.000 description 3
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 3
• 229960004441 tyrosine Drugs 0.000 description 3
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
• 239000011701 zinc Substances 0.000 description 3
• UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 2
• 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 2
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 2
• 102000003966 Alpha-1-microglobulin Human genes 0.000 description 2
• 102100033312 Alpha-2-macroglobulin Human genes 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• 206010002556 Ankylosing Spondylitis Diseases 0.000 description 2
• 102000005666 Apolipoprotein A-I Human genes 0.000 description 2
• 108010059886 Apolipoprotein A-I Proteins 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 208000003950 B-cell lymphoma Diseases 0.000 description 2
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 2
• 206010065687 Bone loss Diseases 0.000 description 2
• 241000589969 Borreliella burgdorferi Species 0.000 description 2
• 241000283690 Bos taurus Species 0.000 description 2
• 101000693922 Bos taurus Albumin Proteins 0.000 description 2
• 101500025132 Bos taurus Ubiquitin Proteins 0.000 description 2
• 101500027500 Bos taurus Ubiquitin Proteins 0.000 description 2
• 101500027539 Bos taurus Ubiquitin Proteins 0.000 description 2
• 101500028979 Bos taurus Ubiquitin Proteins 0.000 description 2
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 2
• 102100036849 C-C motif chemokine 24 Human genes 0.000 description 2
• 108010074051 C-Reactive Protein Proteins 0.000 description 2
• 102100032752 C-reactive protein Human genes 0.000 description 2
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 2
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 2
• 108010083647 Chemokine CCL24 Proteins 0.000 description 2
• 101710178035 Chorismate synthase 2 Proteins 0.000 description 2
• 206010009900 Colitis ulcerative Diseases 0.000 description 2
• 102000000503 Collagen Type II Human genes 0.000 description 2
• 108010041390 Collagen Type II Proteins 0.000 description 2
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 2
• 102000012192 Cystatin C Human genes 0.000 description 2
• 108010061642 Cystatin C Proteins 0.000 description 2
• 101710152694 Cysteine synthase 2 Proteins 0.000 description 2
• 102000053602 DNA Human genes 0.000 description 2
• 102000000541 Defensins Human genes 0.000 description 2
• 108010002069 Defensins Proteins 0.000 description 2
• 102100031107 Disintegrin and metalloproteinase domain-containing protein 11 Human genes 0.000 description 2
• 101710121366 Disintegrin and metalloproteinase domain-containing protein 11 Proteins 0.000 description 2
• AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
• 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 2
• 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 2
• 241000206602 Eukaryota Species 0.000 description 2
• 208000009386 Experimental Arthritis Diseases 0.000 description 2
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
• 102000008857 Ferritin Human genes 0.000 description 2
• 108050000784 Ferritin Proteins 0.000 description 2
• 238000008416 Ferritin Methods 0.000 description 2
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
• 102000004864 Fibroblast growth factor 10 Human genes 0.000 description 2
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
• 102000003886 Glycoproteins Human genes 0.000 description 2
• 108090000288 Glycoproteins Proteins 0.000 description 2
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 2
• 102100034221 Growth-regulated alpha protein Human genes 0.000 description 2
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 2
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 2
• NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
• 108010033040 Histones Proteins 0.000 description 2
• 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 2
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 2
• 101000878602 Homo sapiens Immunoglobulin alpha Fc receptor Proteins 0.000 description 2
• 101001063991 Homo sapiens Leptin Proteins 0.000 description 2
• 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 2
• 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 2
• 101000595923 Homo sapiens Placenta growth factor Proteins 0.000 description 2
• 101000800133 Homo sapiens Thyroglobulin Proteins 0.000 description 2
• 108010073816 IgE Receptors Proteins 0.000 description 2
• 102000009438 IgE Receptors Human genes 0.000 description 2
• 102100038005 Immunoglobulin alpha Fc receptor Human genes 0.000 description 2
• 102000004877 Insulin Human genes 0.000 description 2
• 108090001061 Insulin Proteins 0.000 description 2
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
• 102100025306 Integrin alpha-IIb Human genes 0.000 description 2
• 101710149643 Integrin alpha-IIb Proteins 0.000 description 2
• 102000006992 Interferon-alpha Human genes 0.000 description 2
• 108010047761 Interferon-alpha Proteins 0.000 description 2
• 108010066979 Interleukin-27 Proteins 0.000 description 2
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
• 241000282838 Lama Species 0.000 description 2
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
• 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 2
• 102000009112 Mannose-Binding Lectin Human genes 0.000 description 2
• 108010087870 Mannose-Binding Lectin Proteins 0.000 description 2
• 208000034578 Multiple myelomas Diseases 0.000 description 2
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 2
• 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 2
• 239000000020 Nitrocellulose Substances 0.000 description 2
• 108091005461 Nucleic proteins Proteins 0.000 description 2
• 239000004677 Nylon Substances 0.000 description 2
• 241000283973 Oryctolagus cuniculus Species 0.000 description 2
• 102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 description 2
• 101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 description 2
• 102100035194 Placenta growth factor Human genes 0.000 description 2
• 108010071690 Prealbumin Proteins 0.000 description 2
• 102000007584 Prealbumin Human genes 0.000 description 2
• 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 2
• 102100033237 Pro-epidermal growth factor Human genes 0.000 description 2
• 101710098940 Pro-epidermal growth factor Proteins 0.000 description 2
• 201000001263 Psoriatic Arthritis Diseases 0.000 description 2
• 208000036824 Psoriatic arthropathy Diseases 0.000 description 2
• 101000893561 Rattus norvegicus Growth/differentiation factor 10 Proteins 0.000 description 2
• 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 2
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
• 108020004682 Single-Stranded DNA Proteins 0.000 description 2
• 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 description 2
• 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 2
• 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 description 2
• 201000006704 Ulcerative Colitis Diseases 0.000 description 2
• 108091008605 VEGF receptors Proteins 0.000 description 2
• 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 2
• 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 2
• 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 2
• 239000011543 agarose gel Substances 0.000 description 2
• 210000001552 airway epithelial cell Anatomy 0.000 description 2
• 239000013566 allergen Substances 0.000 description 2
• 201000009961 allergic asthma Diseases 0.000 description 2
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 2
• 102000015395 alpha 1-Antitrypsin Human genes 0.000 description 2
• 229940024142 alpha 1-antitrypsin Drugs 0.000 description 2
• 125000000539 amino acid group Chemical group 0.000 description 2
• 229960000723 ampicillin Drugs 0.000 description 2
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
• 230000000890 antigenic effect Effects 0.000 description 2
• 238000003491 array Methods 0.000 description 2
• 230000003305 autocrine Effects 0.000 description 2
• 102000015736 beta 2-Microglobulin Human genes 0.000 description 2
• 108010081355 beta 2-Microglobulin Proteins 0.000 description 2
• 230000003115 biocidal effect Effects 0.000 description 2
• 210000004556 brain Anatomy 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 150000001768 cations Chemical class 0.000 description 2
• 239000002738 chelating agent Substances 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 230000020800 chemokine (C-C motif) ligand 11 production Effects 0.000 description 2
• 210000000038 chest Anatomy 0.000 description 2
• 238000002447 crystallographic data Methods 0.000 description 2
• 231100000433 cytotoxic Toxicity 0.000 description 2
• 230000001472 cytotoxic effect Effects 0.000 description 2
• 230000003013 cytotoxicity Effects 0.000 description 2
• 231100000135 cytotoxicity Toxicity 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 238000004925 denaturation Methods 0.000 description 2
• 230000036425 denaturation Effects 0.000 description 2
• 238000013461 design Methods 0.000 description 2
• XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 2
• 229960002986 dinoprostone Drugs 0.000 description 2
• 238000001962 electrophoresis Methods 0.000 description 2
• 210000003743 erythrocyte Anatomy 0.000 description 2
• 210000002744 extracellular matrix Anatomy 0.000 description 2
• 229940126864 fibroblast growth factor Drugs 0.000 description 2
• 238000000684 flow cytometry Methods 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• 108010006205 fluorescein isothiocyanate bovine serum albumin Proteins 0.000 description 2
• 239000007850 fluorescent dye Substances 0.000 description 2
• 238000009472 formulation Methods 0.000 description 2
• 239000012737 fresh medium Substances 0.000 description 2
• 102000054766 genetic haplotypes Human genes 0.000 description 2
• 208000024908 graft versus host disease Diseases 0.000 description 2
• 210000003714 granulocyte Anatomy 0.000 description 2
• 230000002949 hemolytic effect Effects 0.000 description 2
• 102000049953 human LEP Human genes 0.000 description 2
• 102000047688 human TG Human genes 0.000 description 2
• 230000035874 hyperreactivity Effects 0.000 description 2
• 238000005286 illumination Methods 0.000 description 2
• 230000036039 immunity Effects 0.000 description 2
• 238000003018 immunoassay Methods 0.000 description 2
• 230000016784 immunoglobulin production Effects 0.000 description 2
• 239000012133 immunoprecipitate Substances 0.000 description 2
• 238000009169 immunotherapy Methods 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 2
• 208000014674 injury Diseases 0.000 description 2
• 229940125396 insulin Drugs 0.000 description 2
• 230000008611 intercellular interaction Effects 0.000 description 2
• 102000004114 interleukin 20 Human genes 0.000 description 2
• 108090000681 interleukin 20 Proteins 0.000 description 2
• 108040002014 interleukin-18 receptor activity proteins Proteins 0.000 description 2
• 102000008625 interleukin-18 receptor activity proteins Human genes 0.000 description 2
• 102000003898 interleukin-24 Human genes 0.000 description 2
• 108090000237 interleukin-24 Proteins 0.000 description 2
• 229940100994 interleukin-7 Drugs 0.000 description 2
• 210000002490 intestinal epithelial cell Anatomy 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 210000003734 kidney Anatomy 0.000 description 2
• 230000002147 killing effect Effects 0.000 description 2
• 231100000518 lethal Toxicity 0.000 description 2
• 230000001665 lethal effect Effects 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 210000000265 leukocyte Anatomy 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 201000005202 lung cancer Diseases 0.000 description 2
• 208000020816 lung neoplasm Diseases 0.000 description 2
• 210000003810 lymphokine-activated killer cell Anatomy 0.000 description 2
• 235000010335 lysozyme Nutrition 0.000 description 2
• 210000002540 macrophage Anatomy 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 239000011159 matrix material Substances 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• 238000002844 melting Methods 0.000 description 2
• 230000008018 melting Effects 0.000 description 2
• 239000012528 membrane Substances 0.000 description 2
• 210000004379 membrane Anatomy 0.000 description 2
• 229960000485 methotrexate Drugs 0.000 description 2
• 238000010172 mouse model Methods 0.000 description 2
• 201000006417 multiple sclerosis Diseases 0.000 description 2
• 231100000219 mutagenic Toxicity 0.000 description 2
• 230000003505 mutagenic effect Effects 0.000 description 2
• 201000005962 mycosis fungoides Diseases 0.000 description 2
• 229920001220 nitrocellulos Polymers 0.000 description 2
• 235000015097 nutrients Nutrition 0.000 description 2
• 229920001778 nylon Polymers 0.000 description 2
• 150000002894 organic compounds Chemical class 0.000 description 2
• 239000003960 organic solvent Substances 0.000 description 2
• 230000003349 osteoarthritic effect Effects 0.000 description 2
• 230000002188 osteogenic effect Effects 0.000 description 2
• 230000002018 overexpression Effects 0.000 description 2
• 238000012856 packing Methods 0.000 description 2
• 230000003076 paracrine Effects 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 230000008506 pathogenesis Effects 0.000 description 2
• 239000008188 pellet Substances 0.000 description 2
• 210000001322 periplasm Anatomy 0.000 description 2
• 102000013415 peroxidase activity proteins Human genes 0.000 description 2
• 108040007629 peroxidase activity proteins Proteins 0.000 description 2
• 239000008194 pharmaceutical composition Substances 0.000 description 2
• 239000012071 phase Substances 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• 210000002729 polyribosome Anatomy 0.000 description 2
• 230000003389 potentiating effect Effects 0.000 description 2
• 238000002360 preparation method Methods 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 230000000644 propagated effect Effects 0.000 description 2
• XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 2
• 230000001681 protective effect Effects 0.000 description 2
• 238000002331 protein detection Methods 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
• 238000012289 standard assay Methods 0.000 description 2
• 210000000130 stem cell Anatomy 0.000 description 2
• 230000004936 stimulating effect Effects 0.000 description 2
• 238000003860 storage Methods 0.000 description 2
• 230000001629 suppression Effects 0.000 description 2
• 230000004083 survival effect Effects 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 230000002459 sustained effect Effects 0.000 description 2
• 210000001258 synovial membrane Anatomy 0.000 description 2
• 210000005222 synovial tissue Anatomy 0.000 description 2
• 210000002437 synoviocyte Anatomy 0.000 description 2
• 230000032258 transport Effects 0.000 description 2
• 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 2
• 230000003827 upregulation Effects 0.000 description 2
• 238000005406 washing Methods 0.000 description 2
• 229910052725 zinc Inorganic materials 0.000 description 2
• HKZAAJSTFUZYTO-LURJTMIESA-N (2s)-2-[[2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoic acid Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O HKZAAJSTFUZYTO-LURJTMIESA-N 0.000 description 1
• NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 1
• KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 description 1
• IJJWOSAXNHWBPR-HUBLWGQQSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-(6-hydrazinyl-6-oxohexyl)pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)NN)SC[C@@H]21 IJJWOSAXNHWBPR-HUBLWGQQSA-N 0.000 description 1
• 206010048998 Acute phase reaction Diseases 0.000 description 1
• 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
• 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 101800001761 Alpha-1-microglobulin Proteins 0.000 description 1
• 206010002383 Angina Pectoris Diseases 0.000 description 1
• 102100022987 Angiogenin Human genes 0.000 description 1
• 108010005853 Anti-Mullerian Hormone Proteins 0.000 description 1
• 102000004411 Antithrombin III Human genes 0.000 description 1
• 108090000935 Antithrombin III Proteins 0.000 description 1
• 101710081722 Antitrypsin Proteins 0.000 description 1
• 101710095342 Apolipoprotein B Proteins 0.000 description 1
• 102100040202 Apolipoprotein B-100 Human genes 0.000 description 1
• 108010025628 Apolipoproteins E Proteins 0.000 description 1
• 102000013918 Apolipoproteins E Human genes 0.000 description 1
• 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
• 108010039627 Aprotinin Proteins 0.000 description 1
• 101000716807 Arabidopsis thaliana Protein SCO1 homolog 1, mitochondrial Proteins 0.000 description 1
• 206010003445 Ascites Diseases 0.000 description 1
• 101100136076 Aspergillus oryzae (strain ATCC 42149 / RIB 40) pel1 gene Proteins 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
• 101710113110 B-cell receptor-associated protein 31 Proteins 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 102100037437 Beta-defensin 1 Human genes 0.000 description 1
• 101710125314 Beta-defensin 1 Proteins 0.000 description 1
• 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 1
• 208000006386 Bone Resorption Diseases 0.000 description 1
• 206010051728 Bone erosion Diseases 0.000 description 1
• 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 206010066091 Bronchial Hyperreactivity Diseases 0.000 description 1
• 102100023702 C-C motif chemokine 13 Human genes 0.000 description 1
• 101710112613 C-C motif chemokine 13 Proteins 0.000 description 1
• 102100023701 C-C motif chemokine 18 Human genes 0.000 description 1
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
• 102100036848 C-C motif chemokine 20 Human genes 0.000 description 1
• 102100036846 C-C motif chemokine 21 Human genes 0.000 description 1
• 102100036850 C-C motif chemokine 23 Human genes 0.000 description 1
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
• 102100032366 C-C motif chemokine 7 Human genes 0.000 description 1
• 101710155834 C-C motif chemokine 7 Proteins 0.000 description 1
• 102100034871 C-C motif chemokine 8 Human genes 0.000 description 1
• 101710155833 C-C motif chemokine 8 Proteins 0.000 description 1
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 1
• 102100036150 C-X-C motif chemokine 5 Human genes 0.000 description 1
• 102100036153 C-X-C motif chemokine 6 Human genes 0.000 description 1
• 101710085504 C-X-C motif chemokine 6 Proteins 0.000 description 1
• 102100032528 C-type lectin domain family 11 member A Human genes 0.000 description 1
• 102100024217 CAMPATH-1 antigen Human genes 0.000 description 1
• 210000004366 CD4-positive T-lymphocyte Anatomy 0.000 description 1
• 108010065524 CD52 Antigen Proteins 0.000 description 1
• 210000001239 CD8-positive, alpha-beta cytotoxic T lymphocyte Anatomy 0.000 description 1
• 101150093802 CXCL1 gene Proteins 0.000 description 1
• 101100123850 Caenorhabditis elegans her-1 gene Proteins 0.000 description 1
• 101100421200 Caenorhabditis elegans sep-1 gene Proteins 0.000 description 1
• 102000000584 Calmodulin Human genes 0.000 description 1
• 108010041952 Calmodulin Proteins 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 102000005367 Carboxypeptidases Human genes 0.000 description 1
• 108010006303 Carboxypeptidases Proteins 0.000 description 1
• 102100028892 Cardiotrophin-1 Human genes 0.000 description 1
• 102000011727 Caspases Human genes 0.000 description 1
• 108010076667 Caspases Proteins 0.000 description 1
• 102000004225 Cathepsin B Human genes 0.000 description 1
• 108090000712 Cathepsin B Proteins 0.000 description 1
• 102000005600 Cathepsins Human genes 0.000 description 1
• 108010084457 Cathepsins Proteins 0.000 description 1
• 101710104316 Cell surface-binding protein Proteins 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 108010075016 Ceruloplasmin Proteins 0.000 description 1
• 102100023321 Ceruloplasmin Human genes 0.000 description 1
• 108010082155 Chemokine CCL18 Proteins 0.000 description 1
• 108010083698 Chemokine CCL26 Proteins 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• 108010014419 Chemokine CXCL1 Proteins 0.000 description 1
• 102000016950 Chemokine CXCL1 Human genes 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 102000012422 Collagen Type I Human genes 0.000 description 1
• 108010022452 Collagen Type I Proteins 0.000 description 1
• 102000004266 Collagen Type IV Human genes 0.000 description 1
• 108010042086 Collagen Type IV Proteins 0.000 description 1
• 108700040183 Complement C1 Inhibitor Proteins 0.000 description 1
• 102000055157 Complement C1 Inhibitor Human genes 0.000 description 1
• 206010056370 Congestive cardiomyopathy Diseases 0.000 description 1
• 108091035707 Consensus sequence Proteins 0.000 description 1
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
• 108010036949 Cyclosporine Proteins 0.000 description 1
• 101150097493 D gene Proteins 0.000 description 1
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
• 230000004543 DNA replication Effects 0.000 description 1
• 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
• 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 208000016192 Demyelinating disease Diseases 0.000 description 1
• 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
• 201000010046 Dilated cardiomyopathy Diseases 0.000 description 1
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
• 102000001301 EGF receptor Human genes 0.000 description 1
• 108060006698 EGF receptor Proteins 0.000 description 1
• 101150029707 ERBB2 gene Proteins 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 206010060742 Endocrine ophthalmopathy Diseases 0.000 description 1
• 201000009273 Endometriosis Diseases 0.000 description 1
• 108010041308 Endothelial Growth Factors Proteins 0.000 description 1
• 208000037487 Endotoxemia Diseases 0.000 description 1
• 101710191360 Eosinophil cationic protein Proteins 0.000 description 1
• 102100040618 Eosinophil cationic protein Human genes 0.000 description 1
• 229940122601 Esterase inhibitor Drugs 0.000 description 1
• 108010014173 Factor X Proteins 0.000 description 1
• 208000004930 Fatty Liver Diseases 0.000 description 1
• 108010087819 Fc receptors Proteins 0.000 description 1
• 102000009109 Fc receptors Human genes 0.000 description 1
• 102000009123 Fibrin Human genes 0.000 description 1
• 108010073385 Fibrin Proteins 0.000 description 1
• BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
• 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 1
• 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
• 102100028412 Fibroblast growth factor 10 Human genes 0.000 description 1
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
• 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
• 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 1
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 1
• 241000724791 Filamentous phage Species 0.000 description 1
• 102000004315 Forkhead Transcription Factors Human genes 0.000 description 1
• 108090000852 Forkhead Transcription Factors Proteins 0.000 description 1
• 101150099798 GSK1 gene Proteins 0.000 description 1
• 101000766307 Gallus gallus Ovotransferrin Proteins 0.000 description 1
• 101710115997 Gamma-tubulin complex component 2 Proteins 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 1
• 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 1
• 206010018338 Glioma Diseases 0.000 description 1
• 208000009329 Graft vs Host Disease Diseases 0.000 description 1
• 102000001398 Granzyme Human genes 0.000 description 1
• 108060005986 Granzyme Proteins 0.000 description 1
• 102100039165 Heat shock protein beta-1 Human genes 0.000 description 1
• 101710100504 Heat shock protein beta-1 Proteins 0.000 description 1
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
• 102100039869 Histone H2B type F-S Human genes 0.000 description 1
• 101000780591 Homo sapiens AFG3-like protein 2 Proteins 0.000 description 1
• 101000897480 Homo sapiens C-C motif chemokine 2 Proteins 0.000 description 1
• 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 description 1
• 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 description 1
• 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 description 1
• 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 description 1
• 101000942297 Homo sapiens C-type lectin domain family 11 member A Proteins 0.000 description 1
• 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 1
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
• 101001035372 Homo sapiens Histone H2B type F-S Proteins 0.000 description 1
• 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
• 101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 description 1
• 101000960954 Homo sapiens Interleukin-18 Proteins 0.000 description 1
• 101000852964 Homo sapiens Interleukin-27 subunit beta Proteins 0.000 description 1
• 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 1
• 101000973997 Homo sapiens Nucleosome assembly protein 1-like 4 Proteins 0.000 description 1
• 101000629361 Homo sapiens Paraplegin Proteins 0.000 description 1
• 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 description 1
• 101000797623 Homo sapiens Protein AMBP Proteins 0.000 description 1
• 101001076715 Homo sapiens RNA-binding protein 39 Proteins 0.000 description 1
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
• 101500027592 Homo sapiens Transferrin receptor protein 1, serum form Proteins 0.000 description 1
• 101000851030 Homo sapiens Vascular endothelial growth factor receptor 3 Proteins 0.000 description 1
• 102000002265 Human Growth Hormone Human genes 0.000 description 1
• 108010000521 Human Growth Hormone Proteins 0.000 description 1
• 239000000854 Human Growth Hormone Substances 0.000 description 1
• 108091006905 Human Serum Albumin Proteins 0.000 description 1
• 208000013016 Hypoglycemia Diseases 0.000 description 1
• 101150088952 IGF1 gene Proteins 0.000 description 1
• 108010042653 IgA receptor Proteins 0.000 description 1
• 101150002416 Igf2 gene Proteins 0.000 description 1
• 101710139711 IkB-like protein Proteins 0.000 description 1
• 108010058683 Immobilized Proteins Proteins 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
• 102000013463 Immunoglobulin Light Chains Human genes 0.000 description 1
• 108010065825 Immunoglobulin Light Chains Proteins 0.000 description 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
• 102000003746 Insulin Receptor Human genes 0.000 description 1
• 108010001127 Insulin Receptor Proteins 0.000 description 1
• 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
• 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
• 102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 1
• 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
• 102100025947 Insulin-like growth factor II Human genes 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 102000004559 Interleukin-13 Receptors Human genes 0.000 description 1
• 108010017511 Interleukin-13 Receptors Proteins 0.000 description 1
• 102100039898 Interleukin-18 Human genes 0.000 description 1
• 108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
• 102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
• 101710081123 Interleukin-27 subunit alpha Proteins 0.000 description 1
• 102100036712 Interleukin-27 subunit beta Human genes 0.000 description 1
• 108010038486 Interleukin-4 Receptors Proteins 0.000 description 1
• 208000029523 Interstitial Lung disease Diseases 0.000 description 1
• 108010044467 Isoenzymes Proteins 0.000 description 1
• 101150008942 J gene Proteins 0.000 description 1
• 206010023203 Joint destruction Diseases 0.000 description 1
• 108010076876 Keratins Proteins 0.000 description 1
• 102000011782 Keratins Human genes 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
• 108010063045 Lactoferrin Proteins 0.000 description 1
• 102000010445 Lactoferrin Human genes 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
• 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
• 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
• 208000004852 Lung Injury Diseases 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• 102100035304 Lymphotactin Human genes 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 101710187853 Macrophage metalloelastase Proteins 0.000 description 1
• 102000004378 Melanocortin Receptors Human genes 0.000 description 1
• 108090000950 Melanocortin Receptors Proteins 0.000 description 1
• 102000005741 Metalloproteases Human genes 0.000 description 1
• 108010006035 Metalloproteases Proteins 0.000 description 1
• 102100030335 Midkine Human genes 0.000 description 1
• 108010092801 Midkine Proteins 0.000 description 1
• 102000015728 Mucins Human genes 0.000 description 1
• 108010063954 Mucins Proteins 0.000 description 1
• 108010014251 Muramidase Proteins 0.000 description 1
• 102000016943 Muramidase Human genes 0.000 description 1
• 101100370002 Mus musculus Tnfsf14 gene Proteins 0.000 description 1
• 102000047918 Myelin Basic Human genes 0.000 description 1
• 102000006386 Myelin Proteins Human genes 0.000 description 1
• 108010083674 Myelin Proteins Proteins 0.000 description 1
• 101710107068 Myelin basic protein Proteins 0.000 description 1
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
• 102100034296 Natriuretic peptides A Human genes 0.000 description 1
• 206010028851 Necrosis Diseases 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 206010029164 Nephrotic syndrome Diseases 0.000 description 1
• 108010025020 Nerve Growth Factor Proteins 0.000 description 1
• 102000015336 Nerve Growth Factor Human genes 0.000 description 1
• 108090000742 Neurotrophin 3 Proteins 0.000 description 1
• 108090000099 Neurotrophin-4 Proteins 0.000 description 1
• 108010015406 Neurturin Proteins 0.000 description 1
• 102100021584 Neurturin Human genes 0.000 description 1
• 206010029379 Neutrophilia Diseases 0.000 description 1
• 102100036518 Nucleoside diphosphate phosphatase ENTPD5 Human genes 0.000 description 1
• 102000004140 Oncostatin M Human genes 0.000 description 1
• 108090000630 Oncostatin M Proteins 0.000 description 1
• 102000007990 Organic Anion Transporters Human genes 0.000 description 1
• 108010089503 Organic Anion Transporters Proteins 0.000 description 1
• 108010061952 Orosomucoid Proteins 0.000 description 1
• 102000012404 Orosomucoid Human genes 0.000 description 1
• 102000008108 Osteoprotegerin Human genes 0.000 description 1
• 108010035042 Osteoprotegerin Proteins 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 108091008606 PDGF receptors Proteins 0.000 description 1
• 108091081548 Palindromic sequence Proteins 0.000 description 1
• 206010034277 Pemphigoid Diseases 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 108010067902 Peptide Library Proteins 0.000 description 1
• KHGNFPUMBJSZSM-UHFFFAOYSA-N Perforine Natural products COC1=C2CCC(O)C(CCC(C)(C)O)(OC)C2=NC2=C1C=CO2 KHGNFPUMBJSZSM-UHFFFAOYSA-N 0.000 description 1
• 241000157426 Pernis Species 0.000 description 1
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
• 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
• 108010001014 Plasminogen Activators Proteins 0.000 description 1
• 102000001938 Plasminogen Activators Human genes 0.000 description 1
• 102100036154 Platelet basic protein Human genes 0.000 description 1
• 108090000778 Platelet factor 4 Proteins 0.000 description 1
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
• 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 1
• 101710193132 Pre-hexon-linking protein VIII Proteins 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
• 102000010498 Receptor Activator of Nuclear Factor-kappa B Human genes 0.000 description 1
• 108010038036 Receptor Activator of Nuclear Factor-kappa B Proteins 0.000 description 1
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
• 101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 description 1
• 102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 208000002200 Respiratory Hypersensitivity Diseases 0.000 description 1
• 102100023361 SAP domain-containing ribonucleoprotein Human genes 0.000 description 1
• 238000011803 SJL/J (JAX™ mice strain) Methods 0.000 description 1
• 101001117144 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) [Pyruvate dehydrogenase (acetyl-transferring)] kinase 1, mitochondrial Proteins 0.000 description 1
• 102400001107 Secretory component Human genes 0.000 description 1
• 229920002684 Sepharose Polymers 0.000 description 1
• 206010040047 Sepsis Diseases 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 102000013275 Somatomedins Human genes 0.000 description 1
• 102000019197 Superoxide Dismutase Human genes 0.000 description 1
• 108010012715 Superoxide dismutase Proteins 0.000 description 1
• 230000005867 T cell response Effects 0.000 description 1
• 101710194518 T4 protein Proteins 0.000 description 1
• 108010004408 TRPP Cation Channels Proteins 0.000 description 1
• 108010006785 Taq Polymerase Proteins 0.000 description 1
• 108020005038 Terminator Codon Proteins 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• 208000007536 Thrombosis Diseases 0.000 description 1
• 102100031372 Thymidine phosphorylase Human genes 0.000 description 1
• 108700023160 Thymidine phosphorylases Proteins 0.000 description 1
• 108010034949 Thyroglobulin Proteins 0.000 description 1
• 102000009843 Thyroglobulin Human genes 0.000 description 1
• 102100027188 Thyroid peroxidase Human genes 0.000 description 1
• 101710113649 Thyroid peroxidase Proteins 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• 102000007238 Transferrin Receptors Human genes 0.000 description 1
• 102400000838 Transferrin receptor protein 1, serum form Human genes 0.000 description 1
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
• 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 1
• 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 1
• 206010069363 Traumatic lung injury Diseases 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 101710187743 Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 description 1
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 1
• 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
• 108090000848 Ubiquitin Proteins 0.000 description 1
• 102000044159 Ubiquitin Human genes 0.000 description 1
• 206010046851 Uveitis Diseases 0.000 description 1
• 102100033179 Vascular endothelial growth factor receptor 3 Human genes 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 101710179590 Vitamin D-binding protein Proteins 0.000 description 1
• 102000050760 Vitamin D-binding protein Human genes 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 230000004658 acute-phase response Effects 0.000 description 1
• 230000006978 adaptation Effects 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 229940009456 adriamycin Drugs 0.000 description 1
• 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
• 230000036428 airway hyperreactivity Effects 0.000 description 1
• 230000010085 airway hyperresponsiveness Effects 0.000 description 1
• 230000001476 alcoholic effect Effects 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 230000037446 allergic sensitization Effects 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 229910021529 ammonia Inorganic materials 0.000 description 1
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 239000001166 ammonium sulphate Substances 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 238000004873 anchoring Methods 0.000 description 1
• 230000002491 angiogenic effect Effects 0.000 description 1
• 108010072788 angiogenin Proteins 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000003429 anti-cardiolipin effect Effects 0.000 description 1
• 230000002494 anti-cea effect Effects 0.000 description 1
• 239000000868 anti-mullerian hormone Substances 0.000 description 1
• 230000001188 anti-phage Effects 0.000 description 1
• 230000001475 anti-trypsic effect Effects 0.000 description 1
• 230000000840 anti-viral effect Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 229960005348 antithrombin iii Drugs 0.000 description 1
• 108010026054 apolipoprotein SAA Proteins 0.000 description 1
• 229960004405 aprotinin Drugs 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 230000002917 arthritic effect Effects 0.000 description 1
• 210000000544 articulatio talocruralis Anatomy 0.000 description 1
• 210000004507 artificial chromosome Anatomy 0.000 description 1
• 229940072107 ascorbate Drugs 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical group N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 description 1
• 210000001130 astrocyte Anatomy 0.000 description 1
• 230000001746 atrial effect Effects 0.000 description 1
• 239000005667 attractant Substances 0.000 description 1
• 230000001363 autoimmune Effects 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 108700041737 bcl-2 Genes Proteins 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 229940125388 beta agonist Drugs 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
• 230000008499 blood brain barrier function Effects 0.000 description 1
• 210000000601 blood cell Anatomy 0.000 description 1
• 210000001218 blood-brain barrier Anatomy 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 230000024279 bone resorption Effects 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• 210000004781 brain capillary Anatomy 0.000 description 1
• 210000000424 bronchial epithelial cell Anatomy 0.000 description 1
• 230000036427 bronchial hyperreactivity Effects 0.000 description 1
• 208000000594 bullous pemphigoid Diseases 0.000 description 1
• BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 238000005251 capillar electrophoresis Methods 0.000 description 1
• 210000000234 capsid Anatomy 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 108010031762 cardiodilatin Proteins 0.000 description 1
• 108010041776 cardiotrophin 1 Proteins 0.000 description 1
• 230000008355 cartilage degradation Effects 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000021164 cell adhesion Effects 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 239000002771 cell marker Substances 0.000 description 1
• 230000004663 cell proliferation Effects 0.000 description 1
• 210000004671 cell-free system Anatomy 0.000 description 1
• 230000007969 cellular immunity Effects 0.000 description 1
• 230000008614 cellular interaction Effects 0.000 description 1
• 230000005754 cellular signaling Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 238000010382 chemical cross-linking Methods 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 230000031902 chemoattractant activity Effects 0.000 description 1
• BFPSDSIWYFKGBC-UHFFFAOYSA-N chlorotrianisene Chemical compound C1=CC(OC)=CC=C1C(Cl)=C(C=1C=CC(OC)=CC=1)C1=CC=C(OC)C=C1 BFPSDSIWYFKGBC-UHFFFAOYSA-N 0.000 description 1
• 239000012539 chromatography resin Substances 0.000 description 1
• 239000013611 chromosomal DNA Substances 0.000 description 1
• 229960001265 ciclosporin Drugs 0.000 description 1
• DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
• 229960004316 cisplatin Drugs 0.000 description 1
• 230000009668 clonal growth Effects 0.000 description 1
• 230000015271 coagulation Effects 0.000 description 1
• 238000005345 coagulation Methods 0.000 description 1
• 206010009887 colitis Diseases 0.000 description 1
• 230000036569 collagen breakdown Effects 0.000 description 1
• 230000000112 colonic effect Effects 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 108010030175 colony inhibiting factor Proteins 0.000 description 1
• 239000011365 complex material Substances 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 239000012050 conventional carrier Substances 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 210000004087 cornea Anatomy 0.000 description 1
• 239000003246 corticosteroid Substances 0.000 description 1
• 229960001334 corticosteroids Drugs 0.000 description 1
• 230000000139 costimulatory effect Effects 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 239000003431 cross linking reagent Substances 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 201000007241 cutaneous T cell lymphoma Diseases 0.000 description 1
• 229930182912 cyclosporin Natural products 0.000 description 1
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000005860 defense response to virus Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 239000008367 deionised water Substances 0.000 description 1
• 229910021641 deionized water Inorganic materials 0.000 description 1
• 210000004443 dendritic cell Anatomy 0.000 description 1
• 230000000994 depressogenic effect Effects 0.000 description 1
• 229960003957 dexamethasone Drugs 0.000 description 1
• UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
• 208000033679 diabetic kidney disease Diseases 0.000 description 1
• 125000001142 dicarboxylic acid group Chemical group 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• 239000002934 diuretic Substances 0.000 description 1
• 108010039433 dolichos biflorus agglutinin Proteins 0.000 description 1
• 239000003792 electrolyte Substances 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 230000002124 endocrine Effects 0.000 description 1
• 210000004696 endometrium Anatomy 0.000 description 1
• 210000001163 endosome Anatomy 0.000 description 1
• 238000012407 engineering method Methods 0.000 description 1
• 231100000655 enterotoxin Toxicity 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 239000002329 esterase inhibitor Substances 0.000 description 1
• 239000000262 estrogen Substances 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 229950003499 fibrin Drugs 0.000 description 1
• 230000020764 fibrinolysis Effects 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 239000012847 fine chemical Substances 0.000 description 1
• 108700014844 flt3 ligand Proteins 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 101150054895 ftsH gene Proteins 0.000 description 1
• 239000003626 gastrointestinal polypeptide Substances 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 230000005484 gravity Effects 0.000 description 1
• 208000025750 heavy chain disease Diseases 0.000 description 1
• 210000002443 helper t lymphocyte Anatomy 0.000 description 1
• 208000029824 high grade glioma Diseases 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 229960001340 histamine Drugs 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 102000054037 human AFG3L2 Human genes 0.000 description 1
• 102000055335 human SPG7 Human genes 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 229940106780 human fibrinogen Drugs 0.000 description 1
• 230000028996 humoral immune response Effects 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 230000009610 hypersensitivity Effects 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 238000001597 immobilized metal affinity chromatography Methods 0.000 description 1
• 230000003100 immobilizing effect Effects 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000002649 immunization Methods 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 238000003365 immunocytochemistry Methods 0.000 description 1
• 238000003125 immunofluorescent labeling Methods 0.000 description 1
• 230000002055 immunohistochemical effect Effects 0.000 description 1
• 230000002621 immunoprecipitating effect Effects 0.000 description 1
• 230000001024 immunotherapeutic effect Effects 0.000 description 1
• 230000002637 immunotoxin Effects 0.000 description 1
• 239000002596 immunotoxin Substances 0.000 description 1
• 231100000608 immunotoxin Toxicity 0.000 description 1
• 229940051026 immunotoxin Drugs 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 238000007901 in situ hybridization Methods 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 239000011261 inert gas Substances 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 230000004941 influx Effects 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 239000000893 inhibin Substances 0.000 description 1
• 229940068935 insulin-like growth factor 2 Drugs 0.000 description 1
• 102000006495 integrins Human genes 0.000 description 1
• 108010044426 integrins Proteins 0.000 description 1
• 229940074383 interleukin-11 Drugs 0.000 description 1
• 230000019703 interleukin-16 production Effects 0.000 description 1
• 108040006849 interleukin-2 receptor activity proteins Proteins 0.000 description 1
• 229940124829 interleukin-23 Drugs 0.000 description 1
• 229940100602 interleukin-5 Drugs 0.000 description 1
• 229940100601 interleukin-6 Drugs 0.000 description 1
• 230000021995 interleukin-8 production Effects 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 230000004068 intracellular signaling Effects 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 238000001155 isoelectric focusing Methods 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 208000018937 joint inflammation Diseases 0.000 description 1
• 210000002510 keratinocyte Anatomy 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
• 229940078795 lactoferrin Drugs 0.000 description 1
• 235000021242 lactoferrin Nutrition 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
• 108010052968 leupeptin Proteins 0.000 description 1
• 210000003041 ligament Anatomy 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 231100000515 lung injury Toxicity 0.000 description 1
• 108010019677 lymphotactin Proteins 0.000 description 1
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 229960000274 lysozyme Drugs 0.000 description 1
• 239000004325 lysozyme Substances 0.000 description 1
• 201000004792 malaria Diseases 0.000 description 1
• 201000011614 malignant glioma Diseases 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
• AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• 230000002906 microbiologic effect Effects 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 239000002480 mineral oil Substances 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 230000000921 morphogenic effect Effects 0.000 description 1
• 210000003097 mucus Anatomy 0.000 description 1
• 239000003471 mutagenic agent Substances 0.000 description 1
• 108700021654 myb Genes Proteins 0.000 description 1
• 210000005012 myelin Anatomy 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 230000002107 myocardial effect Effects 0.000 description 1
• 210000000651 myofibroblast Anatomy 0.000 description 1
• OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 1
• 230000001452 natriuretic effect Effects 0.000 description 1
• 230000017074 necrotic cell death Effects 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 229940053128 nerve growth factor Drugs 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 239000002858 neurotransmitter agent Substances 0.000 description 1
• 210000003458 notochord Anatomy 0.000 description 1
• 238000010899 nucleation Methods 0.000 description 1
• 108010028546 nucleoside-diphosphatase Proteins 0.000 description 1
• XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 239000011368 organic material Substances 0.000 description 1
• 201000008482 osteoarthritis Diseases 0.000 description 1
• 210000000963 osteoblast Anatomy 0.000 description 1
• 238000012261 overproduction Methods 0.000 description 1
• 238000004091 panning Methods 0.000 description 1
• 230000006320 pegylation Effects 0.000 description 1
• 101150040383 pel2 gene Proteins 0.000 description 1
• 101150050446 pelB gene Proteins 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 108010091212 pepstatin Proteins 0.000 description 1
• 229950000964 pepstatin Drugs 0.000 description 1
• FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 238000010647 peptide synthesis reaction Methods 0.000 description 1
• 239000000816 peptidomimetic Substances 0.000 description 1
• 229930192851 perforin Natural products 0.000 description 1
• 210000004303 peritoneum Anatomy 0.000 description 1
• 230000002688 persistence Effects 0.000 description 1
• 108700010839 phage proteins Proteins 0.000 description 1
• 150000008300 phosphoramidites Chemical class 0.000 description 1
• 210000002826 placenta Anatomy 0.000 description 1
• 229940012957 plasmin Drugs 0.000 description 1
• 229940127126 plasminogen activator Drugs 0.000 description 1
• 210000004180 plasmocyte Anatomy 0.000 description 1
• 230000010118 platelet activation Effects 0.000 description 1
• 108010017843 platelet-derived growth factor A Proteins 0.000 description 1
• 108010000685 platelet-derived growth factor AB Proteins 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 208000037244 polycythemia vera Diseases 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 150000003180 prostaglandins Chemical class 0.000 description 1
• 230000006337 proteolytic cleavage Effects 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 239000002287 radioligand Substances 0.000 description 1
• QGFSVPWZEPKNDV-BRTFOEFASA-N ranp Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)[C@@H](C)CC)C1=CC=CC=C1 QGFSVPWZEPKNDV-BRTFOEFASA-N 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 230000008707 rearrangement Effects 0.000 description 1
• 108010043277 recombinant soluble CD4 Proteins 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 230000000306 recurrent effect Effects 0.000 description 1
• 210000003289 regulatory T cell Anatomy 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 230000019254 respiratory burst Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 210000001525 retina Anatomy 0.000 description 1
• 206010039083 rhinitis Diseases 0.000 description 1
• 239000012146 running buffer Substances 0.000 description 1
• 229940076279 serotonin Drugs 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 239000002002 slurry Substances 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 230000035882 stress Effects 0.000 description 1
• 238000012916 structural analysis Methods 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 230000009044 synergistic interaction Effects 0.000 description 1
• 230000008409 synovial inflammation Effects 0.000 description 1
• 238000010189 synthetic method Methods 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 210000002435 tendon Anatomy 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 229960002175 thyroglobulin Drugs 0.000 description 1
• 206010043778 thyroiditis Diseases 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 238000012549 training Methods 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 239000012581 transferrin Substances 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• 229940099456 transforming growth factor beta 1 Drugs 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• 150000005691 triesters Chemical class 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 210000002993 trophoblast Anatomy 0.000 description 1
• 230000001810 trypsinlike Effects 0.000 description 1
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 210000001835 viscera Anatomy 0.000 description 1
• 102100036537 von Willebrand factor Human genes 0.000 description 1